News & Events

News & Events

5/23/23


QuidelOrtho to Participate in William Blair 43rd Annual Growth Stock Conference

Read more

5/8/23


QUIDELORTHO RECEIVES FDA DE NOVO CLASSIFICATION FOR TWO SARS-CoV-2 ANTIBODY TESTS: VITROS® IMMUNODIAGNOSTIC PRODUCTS ANTI-SARS-COV-2 TOTAL TEST AND VITROS® IMMUNODIAGNOSTIC PRODUCTS ANTI-SARS-COV-2 IgG TEST

Read more

5/3/23


QuidelOrtho Reports First Quarter 2023 Financial Results

Read more

4/13/23


QuidelOrtho Reports Preliminary Revenue Results for the First Quarter 2023

Read more

3/29/23


Celebrate and be inspired — Lab Week 2023 Keynote webinar available now

Read more

3/28/23


QuidelOrtho Announces the Formation of the International QuidelOrtho Women’s Leadership Network (QWLN)

Read more

3/8/23


QuidelOrtho Receives De Novo FDA Authorization for Sofia® 2 SARS Antigen+ FIA

Read more

3/2/23


QuidelOrtho to Participate in the Raymond James 44th Annual Institutional Investor Conference

Read more

2/15/23


QuidelOrtho Reports Fourth Quarter and Full Year 2022 Financial Results

Read more

1/06/23


QuidelOrtho Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022

Read more

12/29/22


QuidelOrtho to Present at the J.P. Morgan Healthcare Conference

Read more

12/27/22


Jets Partnered With QuidelOrtho and American Red Cross to Host Holiday Blood Drive

Read more

12/19/22


Health Canada Grants License for Quidel® TriageTrue® High-Sensitivity Troponin I Test to Aid in the Diagnosis of Myocardial Infarction

Read more

11/02/22


QuidelOrtho Reports Third Quarter 2022 Financial Results

Read more

12/12/22


QuidelOrtho Announces Separation of Chairman and Chief Executive Officer Roles

Read more

12/01/22


QuidelOrtho to Host Investor Day on December 13, 2022

Read more

11/02/22


QuidelOrtho Reports Third Quarter 2022 Financial Results

Read more

10/12/22


QuidelOrtho Reports Preliminary Revenue Results for Third Quarter 2022

Read more

09/06/22


QuidelOrtho to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

Read more

09/01/22


Quidel and World Champion Los Angeles Rams Partner to Combat COVID-19 and Promote Health Awareness in the L.A. Community

Read more

08/18/22


QuidelOrtho Announces $300 Million Share Repurpose Authorization

Read more

08/16/22


QuidelOrtho Joins Alliance for a Strong Blood Supply Launched by Association for the Advancement of Blood & Biotherapies

Read more

08/10/22


Podcast: QuidelOrtho provides easier, faster test results with new molecular platform

Read more

08/05/22


QuidelOrtho Reports Second Quarter 2022 Financial Results

Read more

07/26/22


Ortho Ranks No. 1 in Customer Satisfaction for 5 Years in a Row (prnewswire.com)

Read more

07/19/22


Quidel Named First Partner at SDSU Mission Valley Innovation District, Founding Partner at Snapdragon Stadium

Read more

07/12/22


Quidel Corporation and the American Heart Association join forces to advance education and awareness of heart disease in San Diego County

Read more

06/07/22


Here’s How San Diego Biotech Helped Fight The COVID-19 Pandemic

Read More

05/27/22


QuidelOrtho Formed by the Completion of Quidel’s Acquisition of Ortho Clinical Diagnostics

Read More

05/26/22


Quidel and Ortho Announce Expected Closing of Ortho Transaction

Read More

05/16/22


Quidel Announces Stockholder Approval of Ortho Acquisition and Business Combination

Read More

05/08/22


Quidel Corporation and Ortho Clinical Diagnostics to exhibit at the 2022 AACC Annual Scientific Meeting + Clinical Lab Expo

Read More

05/04/22


Quidel Reports First Quarter 2022 Financial Results

Read More

05/01/22


How Quidel Navigated COVID-19: A conversation with Quidel President and CEO Doug Bryant

Read More

12/23/21


Quidel Corporate Signs Definitive Agreement to Acquire Ortho Clinical Diagnostics

Read More